Softwr

AI · head to head

LatchBio vs Replika

LatchBio logo

LatchBio

AI

AI agents that run bioinformatics analyses, from a company that pivoted from workflow hosting

From
On request
Rated
-
Replika logo

Replika

AI

AI companion for meaningful conversations

From
Free
Rated
-

The short version

  • Only Replika has a free tier, so it costs nothing to try first.
  • Each has a real cost: LatchBio the company has pivoted from hosted bioinformatics workflows to AI agents, so organisations that adopted the earlier SDK and workflow product are now on a line that is no longer the strategic focus.; Replika pricing not published on main website or pricing page
  • They diverge on capability: LatchBio covers Agent driven analysis, Replika covers Conversational AI.
  • Prices and features above were last checked on 31 August 2026.

Where they differ

Only the attributes on which LatchBio and Replika actually diverge.

Attributes where LatchBio and Replika differ
AttributeLatchBioReplika
Starting priceOn requestFree
Pricing modelquotefreemium
Free tierNoYes
PlatformsWebIos, Android, Web
FoundedUnknown2016

Identical on both: user rating (Not yet rated), category (AI).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in LatchBio

  • Agent driven analysis
  • Multi assay support
  • Published benchmarks
  • White labelled portals
  • Common file format handling
  • Managed compute

Only in Replika

  • Conversational AI
  • Memory
  • Emotional support
  • Voice calls
  • AR features
  • Mobile apps
  • Ios support
  • Android support

What people use each for

The jobs each tool is most often brought in to do.

LatchBio

  • A small biotech with sequencing data and no bioinformatician who needs a first pass differential expression or cell type annotation quicklynot Replika
  • An assay or kit vendor that wants to give customers an analysis portal under its own branding rather than shipping raw filesnot Replika
  • A wet lab scientist who wants to explore a dataset interactively before commissioning a formal analysis from a core facilitynot Replika
  • A research group benchmarking agent produced analyses against its own established pipeline to decide how much routine work can be delegatednot Replika

Replika

  • ai tools managementnot LatchBio
  • Workflow automationnot LatchBio
  • Reportingnot LatchBio

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

LatchBio

  • The company has pivoted from hosted bioinformatics workflows to AI agents, so organisations that adopted the earlier SDK and workflow product are now on a line that is no longer the strategic focus.
  • Agent generated analysis code has to be validated by someone who could have written it, which inverts the value proposition for the small labs that most need it and cannot check the output.
  • No pricing is published, so the cost of routine agent analysis at team scale cannot be estimated without contacting sales, and compute billed through the platform makes the bill usage dependent.
  • Regulated use is a poor fit: an agent that writes non deterministic analysis code is difficult to validate under GxP, so this is a research tool rather than something that will sit in a regulated diagnostic or submission workflow.
  • The vendor publishes its own benchmarks, which is more than most competitors do, but self reported benchmarks on selected datasets are not a substitute for testing the agent on your own data before committing.

Replika

  • Pricing not published on main website or pricing page

Pricing, plan by plan

LatchBio

On request
  • LatchBio Platform$undefined/year
    • Quoted through a sales process
    • Interactive sandbox available for trying the agent before contracting
    • Enterprise and white labelled portal deployments priced separately

Replika

Free
  • FreeFree
    • Basic conversations
    • Memory
  • Pro$7.99/month
    • All features
    • Voice calls
    • AR

Which should you pick?

Choose LatchBio if

  • You need agent driven analysis.
  • You also want multi assay support.

Choose Replika if

  • You need conversational ai.
  • You want to start without paying.
  • You work on Ios, Android, Web.
  • You also want memory.

Questions people ask

Is LatchBio or Replika better?
Neither clearly leads. LatchBio starts at On request and Replika at Free, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, LatchBio or Replika?
Replika has a free tier; the other does not. Paid plans start at On request for LatchBio and Free for Replika.
Does LatchBio or Replika run on more platforms?
LatchBio runs on Web. Replika runs on Ios, Android, Web.
Can I use Replika for free?
Yes. Replika has a free tier, so you can try it without paying. LatchBio starts at On request.
What is LatchBio best used for?
LatchBio is most often used for a small biotech with sequencing data and no bioinformatician who needs a first pass differential expression or cell type annotation quickly, an assay or kit vendor that wants to give customers an analysis portal under its own branding rather than shipping raw files, a wet lab scientist who wants to explore a dataset interactively before commissioning a formal analysis from a core facility, a research group benchmarking agent produced analyses against its own established pipeline to decide how much routine work can be delegated. Of those, a small biotech with sequencing data and no bioinformatician who needs a first pass differential expression or cell type annotation quickly and an assay or kit vendor that wants to give customers an analysis portal under its own branding rather than shipping raw files are not what Replika is typically brought in for.
What can LatchBio do that Replika cannot?
LatchBio covers Agent driven analysis, Multi assay support, Published benchmarks, White labelled portals. Replika covers Conversational AI, Memory, Emotional support, Voice calls.

Answered from the vendors’ own pages

LatchBio: Is LatchBio still selling the original workflow platform?

The company is now led by agent.bio and its agent products. Buyers evaluating the older Python SDK workflow platform should confirm current support directly.

Replika: How much does Replika cost?

Replika does not publish specific pricing information on its website. The app directs users to get the application, suggesting a subscription model exists, but pricing tiers and costs are not disclosed on the public site.

Source
LatchBio: Can I try it before buying?

Yes. There is an interactive sandbox where you can upload data and run the agent before entering a sales conversation.

LatchBio: Is it suitable for regulated work?

Not really. Non deterministic agent generated code is hard to validate under GxP, so treat it as a research and exploration tool.

LatchBio: What data types does it handle?

Single cell RNA sequencing, spatial transcriptomics, epigenomics, proteomics and pharmacology data, ingesting FastQ, H5AD and spreadsheet formats.

Share

Related pages

Other head to heads